About KLM Laboratories Private Limited
Data last updated:
KLM Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2010PTC251089. Its GSTIN is 08AAECK1686P1ZV (Rajasthan). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹93.47 Lakh. It is led by directors Sohan Dadhich (Managing Director) and Pinki Sohan Dadhich (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹448.33 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹14.4 Cr (net margin 3.2%) and EBITDA of ₹32.17 Cr (EBITDA margin 7.2%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 13% over five years.
The company has about 1,749 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹174.24 Cr and satisfied charges of ₹5 Cr on record. Court records list 3 cases involving the company, including 2 filed against it; 2 cases are pending. The company has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2 Cr; the latest was in November 2021. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Zee Laboratories Limited with revenue of ₹463.57 Cr. The company has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,435 overdue payments to 126 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website klmlab.com.
CIN History of KLM Laboratories Private Limited
KLM Laboratories has one previous CIN (Corporate Identification Number): U24230GJ2010PTC063211. The current CIN is U24230MH2010PTC251089, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230MH2010PTC251089 | Current |
| U24230GJ2010PTC063211 | Previous |
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressUnit No – 1004 10th Floor Hubtown Viva W E Highway Jogeshwari Eas, T, Mumbai, Maharashtra, India – 400060
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of KLM Laboratories Private Limited
The main business activities of KLM Laboratories are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of KLM Laboratories Private Limited FY 2025 filings available
KLM Laboratories Private Limited reported revenue of ₹448.33 Cr (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of KLM Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 18% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of KLM Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹32.17 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.4 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of KLM Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of KLM Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of KLM Laboratories Private Limited
KLM Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pinki Sohan Dadhich | Whole-Time Director | 09 Dec 2010 | 15 Years 10 Months | Current |
| Sohan Dadhich Also directs: KLM Wellness Private Limited, KLM Foundation, Apple Life Science Private Limited and 1 more | Managing Director | 09 Dec 2010 | 15 Years 10 Months | Current |
Peer Comparison of KLM Laboratories Private Limited
KLM Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zee Laboratories Limited | ₹463.57 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Aristo Laboratories Private Limited | ₹461.43 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Tevapharm India Private Limited | ₹459.24 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Mumbai, Maharashtra, India |
| Fredun Pharmaceuticals Ltd Listed | ₹456.27 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | Mumbai, Maharashtra, India |
| Hab Pharmaceuticals and Research Limited | ₹448.72 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| KLM Laboratories Private Limited this company | ₹448.33 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
| Medispray Laboratories Private Limited | ₹444.46 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Goa, India |
| Copmed Pharmaceuticals Private Limited | ₹437.53 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | New Delhi, Delhi, India |
| Hazelo Lab Private Limited | ₹431.64 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Chityal, Telangana, India |
| Zydus Hospira Oncology Private Limited | ₹430.96 Cr (FY 2025) | •••• | •••• | 66.0% | •••• | Village Matoda Tal Sanand, Gujarat, India |
| Halewood Laboratories Private Limited | ₹430.29 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below KLM Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of KLM Laboratories Private Limited
KLM Laboratories Private Limited is audited by P.K. Chirania & Associates for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| P.K. Chirania & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of KLM Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of KLM Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Mar 2024 | Hdfc Bank Limited | ₹47.5 Lakh | Open |
| 06 Dec 2023 | Hdfc Bank Limited | ₹21 Lakh | Open |
| 28 Jun 2023 | Yes Bank Limited | ₹42.16 Cr | Open |
| 30 May 2022 | Others | ₹2.87 Cr | Open |
| 12 Mar 2021 | Others | ₹4.93 Cr | Open |
Total charge records: 7 View all charges
Deals & Funding of KLM Laboratories Private Limited
KLM Laboratories Private Limited has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2 Cr; the latest was in November 2021.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Nov 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2018 | Funding round | ₹2 Cr | Investors: Sohan Dadhich HUF, 3 individuals |
| Nov 2012 | Acquisition | ₹45 Lakh | Buyer: an individual |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Sohan Dadhich HUF Seller: an individual |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of KLM Laboratories Private Limited
KLM Laboratories Private Limited has 3 court cases on record: 2 filed against it, 1 where it is another party. 2 cases are pending and 1 is disposed. Status as checked between 30 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
| High courts | 1 | 0 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ananthapur, Andhra Pradesh | Execution petition | Filed against the company by an individual | Pending |
| Bombay High Court | Court case (COMIP) | Company is another party | Pending |
| District court, Ananthapur, Andhra Pradesh | Court case (MPID) | Filed against the company by an individual | Disposed |
Full case history
All 3 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by KLM Laboratories Private Limited
KLM Laboratories Private Limited has 12 MSME Form 1 returns on record between 2019 and 2024, listing 1,435 overdue payments to 126 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 126)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Orbit Lifescience Private Limited | •••• | •••• | •••• |
| Pious Laboratories Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Tureen Specialty Ingredients Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 12 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at KLM Laboratories Private Limited
KLM Laboratories Private Limited has a workforce of 1,749 employees as of Feb 24, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on KLM Laboratories Private Limited
KLM Laboratories Private Limited has 4 board changes on record since 2010: 2 appointments and 2 cessations. The latest: Pinki Sohan Dadhich ceased to be Director on 22 Aug 2012.
7 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for KLM Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of KLM Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of KLM Laboratories Private Limited
KLM Laboratories has 4 GST registrations: 4 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAECK1686P1ZV | Rajasthan | Active | 01 Jul 2017 |
| 24AAECK1686P1Z1 | Gujarat | Active | 01 Jul 2017 |
| 19AAECK1686P1ZS | West Bengal | Active | 30 Jan 2018 |
| 36AAECK1686P1ZW | Telangana | Active | 20 Apr 2022 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of KLM Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KLM Laboratories Private Limited
KLM Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 December 2010 (16+ years old) and is registered under CIN U24230MH2010PTC251089.
KLM Laboratories reported revenue of ₹448.33 Cr for FY 2025 (up 18% YoY).
KLM Laboratories has 2 current directors:
- Sohan Dadhich - Managing Director
- Pinki Sohan Dadhich - Whole-Time Director
KLM Laboratories reported a net profit of ₹14.4 Cr (net margin 3.2%) and EBITDA of ₹32.17 Cr (EBITDA margin 7.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of KLM Laboratories is 22% over three years and 13% over five years. In the latest year (FY 2025) revenue rose 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of KLM Laboratories is 08AAECK1686P1ZV, registered in Rajasthan. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 24AAECK1686P1Z1 (Gujarat), 19AAECK1686P1ZS (West Bengal), 36AAECK1686P1ZW (Telangana).
The CIN (Corporate Identification Number) of KLM Laboratories is U24230MH2010PTC251089. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KLM Laboratories has 3 court cases on record: 2 filed against it. 2 are pending. Most are in the district courts.
KLM Laboratories was incorporated on 09 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
KLM Laboratories has 4 deals on record (2 secondary share transfers, 1 funding round, 1 acquisition), with disclosed funding of ₹2 Cr; the latest was in November 2021.
The peers of KLM Laboratories by revenue are Zee Laboratories Limited, Aristo Laboratories Private Limited, Tevapharm India Private Limited, Fredun Pharmaceuticals Ltd, Hab Pharmaceuticals and Research Limited and 5 more, all in the Pharma industry (Formulations).
Pinki Sohan Dadhich ceased to be Director on 22 Aug 2012. Sohan Dadhich ceased to be Director on 22 Aug 2012. Pinki Sohan Dadhich was appointed as Whole-Time Director on 09 Dec 2010. KLM Laboratories has 4 board changes on record in total.